顺威股份(002676) - 2019 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was CNY 367,390,042.63, representing a year-on-year increase of 7.80%[7] - Net profit attributable to shareholders was CNY 2,012,161.55, a significant increase of 181.61% compared to the same period last year[7] - Basic earnings per share were CNY 0.0028, an increase of 182.35% year-on-year[7] - Total operating revenue for the current period reached ¥367,390,042.63, an increase of 7.4% compared to ¥340,808,869.57 in the previous period[39] - Net profit for the current period was ¥1,834,534.63, a turnaround from a net loss of ¥2,471,022.25 in the previous period[40] - Basic and diluted earnings per share improved to ¥0.0114 from a loss of ¥0.0193[49] - Net profit for the current period is ¥7,746,395.01, a recovery from a net loss of ¥13,784,281.26 in the previous period[48] - Total comprehensive income for the current period is ¥8,971,088.86, compared to a loss of ¥13,830,115.08 in the previous period[49] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,840,475,919.33, a decrease of 1.89% compared to the end of the previous year[7] - Total liabilities decreased to CNY 776,301,929.71 from CNY 820,644,656.98, representing a reduction of about 5.41%[31] - The company's current liabilities totaled CNY 751,022,521.38, down from CNY 796,647,117.57, indicating a decrease of approximately 5.71%[31] - The non-current assets were reported at CNY 692,179,287.85, slightly down from CNY 707,093,218.41, a decline of about 2.11%[30] - Total liabilities amounted to ¥835,144,551.17 as of December 31, 2018[66] - Total equity reached ¥949,301,842.68, indicating a stable financial position[67] Cash Flow - The net cash flow from operating activities was CNY 38,201,535.04, down 25.15% from the previous period[7] - The cash inflow from sales of goods and services was ¥828,083,583.93, down 15.7% from ¥981,935,117.33, highlighting a decline in sales performance[54] - Total cash inflow from operating activities was ¥841,555,418.51, down 15.6% from ¥997,244,959.25 in the previous year, primarily due to a decrease in cash received from sales[54] - The ending cash and cash equivalents balance was ¥160,120,935.70, a decrease from ¥121,978,267.22 year-over-year, reflecting overall cash management challenges[55] Expenses - Total operating costs amounted to ¥365,349,237.73, up from ¥344,832,669.57, reflecting a rise of 5.9%[39] - Research and development expenses surged to ¥13,115,797.29, a significant increase of 245.5% from ¥3,805,229.21 in the previous period[39] - The company experienced an asset impairment loss of ¥2,779,783.76, worsening from a loss of ¥465,923.95 in the previous period[40] - The company experienced an asset impairment loss of ¥14,742,747.03, which increased from ¥6,340,797.97 in the previous period[48] - Financial expenses decreased by 35.13% to ¥12,033,239.67 due to significant exchange rate gains this period[16] Changes in Assets - Accounts receivable increased by 32.34% to CNY 194,771,884.30 due to a higher volume of received bills[15] - Prepayments rose by 100.84% to CNY 12,982,215.07, primarily due to increased advance payments for materials[15] - Construction in progress increased by 189.38% to CNY 7,316,759.95, attributed to equipment purchases not yet installed[15] - Other non-current assets increased by 58.15% to CNY 15,336,710.57, reflecting higher payments for long-term assets[15] - Cash and cash equivalents decreased to ¥168,750,935.70 from ¥178,511,284.64 as of December 31, 2018[29] - Accounts receivable decreased to ¥397,608,185.51 from ¥432,066,715.16 as of December 31, 2018[29] - Inventory decreased to ¥316,535,479.73 from ¥352,418,804.64 as of December 31, 2018[29] Strategic Initiatives - The company plans to continue investing in R&D to drive future growth and innovation[42] - The company reported no violations regarding external guarantees during the reporting period[22]